Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Stratified Multicentre Phase II Clinical Trial of Single Agent ADI-PEG 20TM (Pegylated Arginine Deiminase) in Patients With Malignant Pleural Mesothelioma

NCT01279967 is registered in ClinicalTrials.gov with Barts & The London NHS Trust as lead sponsor.

NCT NCT01279967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01279967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Stratified Multicentre Phase II Clinical Trial of Single Agent ADI-PEG 20TM (Pegylated Arginine Deiminase) in Patients With Malignant Pleural Mesothelioma
Lead sponsor
Barts & The London NHS Trust
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2011
Completion date
March 31, 2015
Enrollment
70 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

malignant pleural mesothelioma